NASDAQ NMS - GLOBAL MARKET · NRIX
+0.63% · +$0.1550 · Vol 539.8K
Live · updated 15:17:23 ET
Nurix Therapeutics Inc

Nurix Therapeutics Inc

Biotechnology
$24.84
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
NRIX
Nurix Therapeutics Inc
Wed Aug 5 · live session · daily score · 2h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Wed Aug 5 · live session · daily score · 2h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NRIX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NRIX catalysts
About Nurix Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
357
Country
US

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$24.91
Day high
$25.40
Day low
$24.54
Previous close
$24.69
52W high
$25.40
-2.19% from high
52W low
$8.24
97% of range
Market cap
$2.6B
EPS
$-3.1500
Beta
1.32
Shares out
103.8M
Volume
539.8K
0.33× rel vol
Avg volume
1.7M
VWAP
$24.93
Price history computed in-house
1W
+5.28%
1M
+3.35%
3M
+52.61%
1Y
+119.67%
YTD
+30.97%
SMA 50 $20.67 · above
SMA 200 $17.23 · above
52W position 97%

NRIX overview

Veridion Score
59
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NRIX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NRIX Form 4 filings
Public disclosures

Congress activity in NRIX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NRIX in the cached public ledger.

Federal contracts

NRIX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NRIX in this window.
Lobbying spend

NRIX lobbying filings, year to date.

Registered lobbying filings matched to Nurix Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NRIX in this window.
Loading news for NRIX
Analyst ratings
Sovereign unlock shows live analyst consensus for NRIX.
Options
Sovereign unlock shows live options positioning for NRIX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.